179 related articles for article (PubMed ID: 33816051)
1. Medication non-adherence among liver transplant recipients.
Jones LS; Serper M
Curr Hepatol Rep; 2020 Dec; 19(4):327-336. PubMed ID: 33816051
[TBL] [Abstract][Full Text] [Related]
2. Impact of Once- Versus Twice-Daily Tacrolimus Dosing on Medication Adherence in Stable Renal Transplant Recipients: A Canadian Single-Center Randomized Controlled Trial.
Paterson TSE; Demian M; Shapiro RJ; Loken Thornton W
Can J Kidney Health Dis; 2019; 6():2054358119867993. PubMed ID: 31452902
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and Safety Evaluation After Conversion From Twice-Daily to Once-Daily Tacrolimus in Stable Liver Transplant Recipients: A Phase 4, Open-Label, Single-Center Study.
Kang WH; Song GW; Moon DB; Hwang S; Kim KH; Jung DH; Park GC; Yoon YI; Cho HD; Kim M; Kim SH; Na BG; Kim SM; Yang G; Lee SG
Transplant Proc; 2021 Dec; 53(10):3000-3006. PubMed ID: 34776265
[TBL] [Abstract][Full Text] [Related]
4. Adherence to immunosuppression in adult lung transplant recipients: prevalence and risk factors.
Bosma OH; Vermeulen KM; Verschuuren EA; Erasmus ME; van der Bij W
J Heart Lung Transplant; 2011 Nov; 30(11):1275-80. PubMed ID: 21724418
[TBL] [Abstract][Full Text] [Related]
5. Adherence to, and patient convenience of, prolonged-release tacrolimus in stable kidney and liver transplant recipients after conversion from immediate-release tacrolimus in routine clinical practice in Switzerland.
Bonani M; Balaphas A; Bedino G; Bühler L; Dutkowski P; Fausch K; Gluderer S; Graf N; Hirt-Minkowski P; Müllhaupt B; Schönholzer C; Schulz MM; Venzin R; Wüthrich RP
Swiss Med Wkly; 2021 Feb; 151():w20453. PubMed ID: 33638353
[TBL] [Abstract][Full Text] [Related]
6. Predictors of Non-adherence to Immunosuppressive Therapy in Asian Liver Transplant Recipients.
Hartono JL; Koh T; Lee GH; Tan PS; Muthiah M; Aw MM; Madhavan K; Kow A; Lim KB
Transplant Proc; 2017; 49(6):1419-1424. PubMed ID: 28736016
[TBL] [Abstract][Full Text] [Related]
7. Safety and Efficacy of Conversion to Once-Daily Tacrolimus from Twice-Daily Tacrolimus in Pediatric Liver Transplant Recipients.
An S; Lee S; Rhu J; Kim JM; Choi GS; Joh JW
J Pediatr Surg; 2023 Oct; 58(10):2054-2058. PubMed ID: 37277238
[TBL] [Abstract][Full Text] [Related]
8. Interventions for increasing immunosuppressant medication adherence in solid organ transplant recipients.
Mellon L; Doyle F; Hickey A; Ward KD; de Freitas DG; McCormick PA; O'Connell O; Conlon P
Cochrane Database Syst Rev; 2022 Sep; 9(9):CD012854. PubMed ID: 36094829
[TBL] [Abstract][Full Text] [Related]
9. Short-term outcomes of paediatric liver transplant recipients after transition to Adult Healthcare Service.
Ferrarese A; Germani G; Lazzaro S; Cananzi M; Russo FP; Senzolo M; Gambato M; Zanetto A; Cillo U; Gringeri E; Perilongo G; Burra P
Liver Int; 2018 Jul; 38(7):1316-1321. PubMed ID: 29205755
[TBL] [Abstract][Full Text] [Related]
10. An observational study evaluating tacrolimus dose, exposure, and medication adherence after conversion from twice- to once-daily tacrolimus in liver and kidney transplant recipients.
Bäckman L; Persson CA
Ann Transplant; 2014 Mar; 19():138-44. PubMed ID: 24637379
[TBL] [Abstract][Full Text] [Related]
11. Reducing the Pill Burden: Immunosuppressant Adherence and Safety after Conversion from a Twice-Daily (IR-Tac) to a Novel Once-Daily (LCP-Tac) Tacrolimus Formulation in 161 Liver Transplant Patients.
Maurer MM; Ibach M; Plewe J; Winter A; Ritschl P; Globke B; Öllinger R; Lurje G; Schöning W; Pratschke J; Eurich D
Biomedicines; 2022 Jan; 10(2):. PubMed ID: 35203481
[TBL] [Abstract][Full Text] [Related]
12. Medication misuse, nonadherence, and clinical outcomes among liver transplant recipients.
Serper M; Patzer RE; Reese PP; Przytula K; Koval R; Ladner DP; Levitsky J; Abecassis MM; Wolf MS
Liver Transpl; 2015 Jan; 21(1):22-8. PubMed ID: 25312406
[TBL] [Abstract][Full Text] [Related]
13. Non-adherence and graft failure in adult liver transplant recipients.
Lieber SR; Volk ML
Dig Dis Sci; 2013 Mar; 58(3):824-34. PubMed ID: 23053889
[TBL] [Abstract][Full Text] [Related]
14. Improved adherence to tacrolimus once-daily formulation in renal recipients: a randomized controlled trial using electronic monitoring.
Kuypers DR; Peeters PC; Sennesael JJ; Kianda MN; Vrijens B; Kristanto P; Dobbels F; Vanrenterghem Y; Kanaan N;
Transplantation; 2013 Jan; 95(2):333-40. PubMed ID: 23263559
[TBL] [Abstract][Full Text] [Related]
15. Conversion From Twice-Daily to Once-Daily Tacrolimus Among Egyptian Living-Donor Kidney Allograft Recipients: A Single-Center Experience.
Bakr MA; Nagib AM; Abbas MH; Donia AF
Exp Clin Transplant; 2019 Oct; 17(5):594-598. PubMed ID: 31050617
[TBL] [Abstract][Full Text] [Related]
16. Optimization of Electronically Monitored Non-Adherence in Highly Adherent Renal Transplant Recipients by Reducing the Dosing Frequency - A Prospective Single-Center Observational Study.
Lieb M; Schiffer M; Erim Y
Patient Prefer Adherence; 2020; 14():1389-1401. PubMed ID: 32821087
[TBL] [Abstract][Full Text] [Related]
17. Improvement of medication adherence with simplified once-daily immunosuppressive regimen in stable kidney transplant recipients: A prospective cohort study.
Oh CK; Bang JB; Kim SJ; Huh KH; Kim SJ; Jeon JS; Han SY; Cho HR; Kwon YJ; Lee SH; Kim YS
Asian J Surg; 2020 Jun; 43(6):660-667. PubMed ID: 31353239
[TBL] [Abstract][Full Text] [Related]
18. Evaluating the economic implications of non-adherence and antibody-mediated rejection in renal transplant recipients: the role of once-daily tacrolimus in the UK.
Muduma G; Odeyemi I; Pollock RF
J Med Econ; 2015; 18(12):1050-9. PubMed ID: 26201252
[TBL] [Abstract][Full Text] [Related]
19. Update on the clinical utility of once-daily tacrolimus in the management of transplantation.
Posadas Salas MA; Srinivas TR
Drug Des Devel Ther; 2014; 8():1183-94. PubMed ID: 25210441
[TBL] [Abstract][Full Text] [Related]
20. Conversion from twice-daily to once-daily tacrolimus in stable liver transplant patients: effectiveness in a real-world setting.
Valente G; Rinaldi L; Sgambato M; Piai G
Transplant Proc; 2013 Apr; 45(3):1273-5. PubMed ID: 23622676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
